Ambev’s stock took a hit as investors grappled with the slow pace of Brazil’s beer market recovery. Despite volume gains expected this quarter, forecasts suggest sales will still fall short of the numbers posted in 2024. The brewer’s shares in Brazil closed down 1.2%, reflecting a growing caution around the company’s ability to regain pre-pandemic momentum.
Volumes Improve but Don’t Fully Recover
Analysts predict Brazilian beer volumes to rise between 5% and 8% year-on-year in Q2, which signals a rebound from last year’s steep 8.9% drop. Still, even optimistic estimates show volumes trailing 2024 levels by roughly 1.6%. This gap worries investors, as a modest 5% increase would leave sales about 4.4% below the benchmark set two years prior. The market’s attention is shifting from pure growth figures to how much of the lost volume Ambev is actually clawing back over time.
Profitability Gains Outweigh Volume Concerns
With volume growth capped, the focus has moved towards profitability metrics. Revenue estimates for the quarter range from R$20.4 billion to R$21.1 billion, while EBITDA is forecasted between R$6.3 billion and R$6.6 billion. Experts believe Ambev’s pricing strategies and premium beer sales, combined with tighter cost controls, could improve margins despite the slower volume recovery. This nuanced outlook signals a shift where pricing power and operational efficiency will be key drivers rather than just sales volume.
This content is for informational purposes and is not investment advice.
